Astellas Pharma, Inc. (ALPMY)
14.67
+0.22
(+1.52%)
USD |
OTCM |
May 08, 16:00
Astellas Pharma Total Assets (Quarterly) : 22.42B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 207.62B |
| Takeda Pharmaceutical Co., Ltd. | 98.30B |
| Daiichi Sankyo Co., Ltd. | 24.38B |
| Eisai Co., Ltd. | 9.482B |
| Chugai Pharmaceutical Co., Ltd. | 14.24B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.91B |
| Shareholders Equity (Quarterly) | 11.51B |
| Debt to Equity Ratio | 0.3091 |
| Current Ratio | 1.167 |
| Net Debt Paydown Yield | 2.07% |